TY - JOUR
T1 - Evaluation and Disposition of Fetal Myelomeningocele Repair Candidates
T2 - A Large Referral Center Experience
AU - Pan, Evelyn T.
AU - Pallapati, Joana
AU - Krueger, Angel
AU - Yepez, Mayel
AU - Vanloh, Sarah
AU - Nassr, Ahmed A.
AU - Espinoza, Jimmy
AU - Shamshirsaz, Alireza A.
AU - Olutoye, Oluyinka O.
AU - Mehollin-Ray, Amy
AU - De Jong, Hester
AU - Castillo, Heidi
AU - Castillo, Jonathan
AU - Whitehead, William E.
AU - Olutoye, Olutoyin A.
AU - Ayres, Nancy
AU - Belfort, Michael A.
AU - Sanz Cortes, Magdalena
N1 - Publisher Copyright:
© 2019 S. Karger AG, Basel.
PY - 2020/2/1
Y1 - 2020/2/1
N2 - Background: Fetal myelomeningocele (fMMC) repair yields superior outcomes to postnatal repair and is increasingly offered at select fetal centers. Objectives: To report the fMMC referral process from initial referral to evaluation and surgical intervention in a large fetal referral center. Methods: We conducted a retrospective cohort study of patients referred to Texas Children's Fetal Center for fMMC between September 2013 and January 2018, reviewing the process from referral to final disposition. The stepwise evaluation included a phone interview followed by multidisciplinary consultation at our fetal center. We modified the Management of Myelomeningocele Study inclusion and exclusion criteria to allow a maternal body mass index of 35-40 on an individual basis. Results: A total of 204 referrals were contacted for a phone interview; 175 (86%) pursued outpatient evaluation, and 80 (46%) of them qualified for repair. Among the eligible patients, 37 (46%) underwent fetoscopic repair, 20 (25%) underwent open repair, and 17 (21%) declined prenatal surgery. Of the 89 noneligible patients (53%) excluded upon outpatient evaluation, 64 (72%) were excluded for fetal and 17 (19%) for maternal reasons. No hindbrain herniation (16%) and maternal BMI and/or hypertension (5%) were the most common reasons for fetal and maternal exclusion, respectively. A total of 31% of our referral population underwent fetal surgery. Conclusions: A small percentage of fMMC referrals ultimately undergo prenatal surgery. Stepwise evaluation and multidisciplinary teams are key to the success of large referral programs.
AB - Background: Fetal myelomeningocele (fMMC) repair yields superior outcomes to postnatal repair and is increasingly offered at select fetal centers. Objectives: To report the fMMC referral process from initial referral to evaluation and surgical intervention in a large fetal referral center. Methods: We conducted a retrospective cohort study of patients referred to Texas Children's Fetal Center for fMMC between September 2013 and January 2018, reviewing the process from referral to final disposition. The stepwise evaluation included a phone interview followed by multidisciplinary consultation at our fetal center. We modified the Management of Myelomeningocele Study inclusion and exclusion criteria to allow a maternal body mass index of 35-40 on an individual basis. Results: A total of 204 referrals were contacted for a phone interview; 175 (86%) pursued outpatient evaluation, and 80 (46%) of them qualified for repair. Among the eligible patients, 37 (46%) underwent fetoscopic repair, 20 (25%) underwent open repair, and 17 (21%) declined prenatal surgery. Of the 89 noneligible patients (53%) excluded upon outpatient evaluation, 64 (72%) were excluded for fetal and 17 (19%) for maternal reasons. No hindbrain herniation (16%) and maternal BMI and/or hypertension (5%) were the most common reasons for fetal and maternal exclusion, respectively. A total of 31% of our referral population underwent fetal surgery. Conclusions: A small percentage of fMMC referrals ultimately undergo prenatal surgery. Stepwise evaluation and multidisciplinary teams are key to the success of large referral programs.
KW - Fetal surgery
KW - Magnetic resonance imaging
KW - Prenatal diagnosis
KW - Preoperative evaluation
KW - Spina bifida
UR - http://www.scopus.com/inward/record.url?scp=85067613902&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85067613902&partnerID=8YFLogxK
U2 - 10.1159/000500451
DO - 10.1159/000500451
M3 - Article
C2 - 31212296
AN - SCOPUS:85067613902
SN - 1015-3837
VL - 47
SP - 115
EP - 122
JO - Fetal Diagnosis and Therapy
JF - Fetal Diagnosis and Therapy
IS - 2
ER -